CTLT241220C90000
- 0.00
- 0.000.00%
Catalent(Delisted) Newsroom
Lennox International to Replace Catalent in S&P 500; BILL Holdings to Join S&P MidCap 400
Express News | Lennox International Set to Join S&P 500 and Bill Holdings to Join S&P MidCap 400
Lennox To Replace Catalent In S&P 500, Effective Prior To Opening Of Trading On Monday, December 23
Correction: Novo Nordisk Controlling Shareholder Completes $16.5 Billion Catalent Buyout
Press Release: Novo Holdings Completes Acquisition of Catalent
Novo Holdings Completes Acquisition of Catalent
Novo's New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. -- Barrons.com
Sector Update: Health Care Stocks Decline Monday Afternoon
Moderna Remains the Most Shorted Among S&P 500 Healthcare Stocks in November
Top Midday Stories: Honeywell Mulls Separation of Aerospace Business; Starbucks Expands Parental Leave for US Store Workers
Novo Nordisk Stock Rises Following Regulatory Clearance of Catalent Deal
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent
Novo Nordisk's Imminent Capacity Increase Is a Significant Positive -- Market Talk
Express News | Novo-Nordisk A/S acquisition of Catalent Trade has been approved for completion.
Key Deals for the Week: Patterson, Hershey & Mondelez, AIG & Nippon and More
Express News | Novo Nordisk: Not Expecting to Initiate a Share Buyback Programme in 2025
Express News | Novo Nordisk: For 2025, Acquisition Is Expected to Have a Mid Single-Digit Negative Impact on Operating Profit Growth
Express News | Novo Nordisk: All Regulatory Closing Conditions Relating to Review of Novo Holdings A/S's Pending Acquisition of Catalent Have Been Fulfilled
Novo Nordisk A/S: The Acquisition of Catalent by Novo Holdings, and the Related Acquisition by Novo Nordisk of Three Manufacturing Sites From Novo Holdings, Is Cleared to Close
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction